Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  PAO Group, Inc.    PAOG


SummaryAll NewsPress ReleasesOfficial PublicationsSector news

PURA Announces Analyst Report Pertaining to Coming 1 for 1 Dividend

share with twitter share with LinkedIn share with facebook
09/11/2020 | 12:40pm EDT

Dallas, Texas--(Newsfile Corp. - September 11, 2020) - Puration, Inc. (OTC Pink: PURA) today announced recent analyst research pertaining to the upcoming planned shareholder dividend for prompt distribution where shareholders are to receive one share of PAO Group, Inc. (OTC Pink: PAOG) for every PURA share held.

Goldman Small Cap Research earlier this week released an update to a previous research report covering PAOG’s cannabis biopharmaceutical business.  The report includes a valuation projection.

The dividend has been declared.  A date of record is pending the necessary process to be set, and a prompt distribution is planned thereafter.  Management did anticipate the date of record process already being complete at this time and expects to have a date imminently.

A second shareholder dividend is in the works and the transaction that would result in the dividend issuance is anticipated to be complete by the end of this month.

Prior to entering into the cannabis marketplace with the acquisition of patented cannabis extraction process licenses, PURA worked in the development of proprietary water purification technologies.  PURA's legacy personal water purification product, Filter2Go remains for sale online to include distribution through Amazon.com

PURA has been approached by a party looking to acquire PURA's legacy water purification assets. The deal under discussion would involve an exchange of stock in a public company for PURA's water purification assets. PURA management would in turn issue the purchase stock to PURA shareholders through a dividend distribution similarly to the dividend distribution underway in conjunction with PURA's recent sale of its cannabis cultivation assets to PAOG.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Puration, Inc.
Brian Shibley,
(800) 861-1350

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/63633

© Newsfilecorp 2020
share with twitter share with LinkedIn share with facebook
All news about PAO GROUP, INC.
09/17PAOG Target, CBD Pharma Development, In Puerto Rico Could Get Boost From COVI..
09/16PAOG Announces Agreement to Build Pharmaceutical Hemp Cultivar Facility on PU..
09/15PAOG Advances RespRx Research Into International CBD Pharma Research Arena
09/15PAOG Goes Global with CBD Pharmaceutical Research to Target $5.8 Billion Mark..
09/14PAOG New Updates Toward Penetrating $5.8B Cannabis Pharmaceutical Market Comi..
09/11PURA Announces Analyst Report Pertaining to Coming 1 for 1 Dividend
09/08PAOG Rated Bullish And Given PPS Target In Updated Analyst Report Published T..
09/02PAOG Announces Goldman Small Cap Research Update Scheduled Next Week
More news
Duration : Period :
PAO Group, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
James C. DiPrima Chief Executive & Financial Officer
Gary C. Bernard Medical Director